We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+2.79%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$772M
AUM Growth
+$184M
Cap. Flow
+$177M
Cap. Flow %
22.88%
Top 10 Hldgs %
12.03%
Holding
720
New
321
Increased
119
Reduced
86
Closed
193

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$11.5M
2
LLY icon
Eli Lilly
LLY
+$10.9M
3
UNH icon
UnitedHealth
UNH
+$9.37M
4
HOLX
Hologic
HOLX
+$8.36M
5
ABBV icon
AbbVie
ABBV
+$7.88M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$14.1M
2
DELL icon
Dell
DELL
+$10.7M
3
TAP icon
Molson Coors Class B
TAP
+$9.81M
4
NFLX icon
Netflix
NFLX
+$8.78M
5
NTB icon
Bank of N.T. Butterfield & Son
NTB
+$8.31M

Sector Composition

Rank Sector Weight
1 Healthcare 21.43%
2 Consumer Discretionary 15.02%
3 Technology 12.44%
4 Communication Services 9.39%
5 Financials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KEY icon
601
KeyCorp
KEY
$24.2B
– –
-17,472
Closed -$213K
KMX icon
602
CarMax
KMX
$8.33B
– –
-37,516
Closed -$2M
LEN icon
603
Lennar Class A
LEN
$20.2B
– –
-25,174
Closed -$1.01M
LILAK icon
604
Liberty Latin America Class C
LILAK
$1.61B
– –
-32,203
Closed -$773K
LKQ icon
605
LKQ Corp
LKQ
$5.76B
– –
-52,101
Closed -$1.85M
LNG icon
606
Cheniere Energy
LNG
$54.1B
– –
-4,579
Closed -$200K
LRCX icon
607
Lam Research
LRCX
$372B
– –
-58,400
Closed -$553K
MATX icon
608
Matsons
MATX
$6.16B
– –
-27,401
Closed -$1.09M
MCK icon
609
McKesson
MCK
$101B
– –
-5,329
Closed -$889K
MHK icon
610
Mohawk Industries
MHK
$7.29B
– –
-6,213
Closed -$1.25M
MNST icon
611
Monster Beverage
MNST
$95.5B
– –
-120,960
Closed -$2.96M
MOH icon
612
Molina Healthcare
MOH
$10.2B
– –
-11,457
Closed -$668K
MPT
613
Medical Properties Trust
MPT
$2.81B
– –
-50,000
Closed -$739K
NBIX icon
614
Neurocrine Biosciences
NBIX
$18.7B
– –
-5,419
Closed -$274K
NBR icon
615
Nabors Industries
NBR
$1.22B
– –
-392
Closed -$238K
NERV icon
616
Minerva Neurosciences
NERV
$187M
– –
-2,560
Closed -$289K
NKTR icon
617
Nektar Therapeutics
NKTR
$2.41B
– –
-1,454
Closed -$375K
NTAP icon
618
NetApp
NTAP
$34.1B
– –
-6,000
Closed -$215K
NTB icon
619
Bank of N.T. Butterfield & Son
NTB
$2.45B
– –
-335,525
Closed -$8.31M
NTNX icon
620
Nutanix
NTNX
$16B
– –
-89,400
Closed -$3.31M
NUS icon
621
Nu Skin
NUS
$254M
– –
-12,580
Closed -$815K
NVDA icon
622
NVIDIA
NVDA
$4.72T
– –
-884,200
Closed -$1.51M
NVS icon
623
Novartis
NVS
$301B
– –
-23,888
Closed -$1.69M
NWL icon
624
Newell Brands
NWL
$2.18B
– –
-71,059
Closed -$3.74M
NYT icon
625
New York Times
NYT
$12.3B
– –
-20,672
Closed -$247K
23 24
25
26 27

Similar funds

FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
X
Xponance Philadelphia, Pennsylvania $14.1B AUM 30.11% 1-Year Est. Return
CM
Capula Management Grand Cayman, Cayman Islands $14.1B AUM 19.14% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Schonfeld Strategic Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, Schonfeld Strategic Advisors held 720 positions worth $772M, up 31% from $589M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Schonfeld Strategic Advisors deployed $177M of net new capital in Q4 2016, opening 321 new positions and adding to 119 existing holdings. Its largest new stake was Eli Lilly: 146,398 shares worth $10.8M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Amazon, an estimated $14.1M trimmed.

  • Schonfeld Strategic Advisors's largest Q4 2016 buy was Eli Lilly: 146,398 shares worth $10.8M.
  • Schonfeld Strategic Advisors added most to Amgen in Q4 2016, an estimated $11.5M increase.
  • Schonfeld Strategic Advisors's biggest Q4 2016 reduction was Amazon, cutting an estimated $14.1M.
  • Schonfeld Strategic Advisors fully exited Bank of N.T. Butterfield & Son in Q4 2016, selling an estimated $8.31M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 12% of its $772M portfolio in Q4 2016.
  • Schonfeld Strategic Advisors opened 321 new positions and closed 193 in Q4 2016.
  • Schonfeld Strategic Advisors's portfolio value rose 31% quarter-over-quarter to $772M.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.